Business & Finance

Global Orally Disintegrating Tablets Market 2019 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast To 2025

Press Release

MarketResearchNest.com adds “Global Orally Disintegrating Tablets Market Insights, Forecast to 2025” new report to its research database. The report spread across 110 pages with multiple tables and figures in it.

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period.

Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.

North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.

The global Orally Disintegrating Tablets market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orally Disintegrating Tablets market based on company, product type, end user and key regions.

Request a sample copy @ https://www.marketresearchnest.com/report/requestsample/630957

This report studies the global market size of Orally Disintegrating Tablets in key regions like North America, Europe, Asia Pacific, Central and South America and Middle East and Africa, focuses on the consumption of Orally Disintegrating Tablets in these regions.

This research report categorizes the global Orally Disintegrating Tablets market by top players/brands, region, type and end user. This report also studies the global Orally Disintegrating Tablets market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report:             

  • Teva
  • Merck
  • Mylan
  • Pfizer
  • Johnson and Johnson
  • GSK
  • Otsuka
  • Eli Lilly and Company
  • AstraZeneca
  • Bristol-Myers Squibb
  • Conquer

Browse full table of contents and data tables @ https://www.marketresearchnest.com/Global-Orally-Disintegrating-Tablets-Market-Insights-Forecast-to-2025.html

Market size by Product

Anti-Psychotics Drug

Anti-Epileptics Drug

Other

Market size by End User

CNS Diseases

Gastrointestinal Diseases

CVS Diseases

Other

Purchase Report Copy @ https://www.marketresearchnest.com/report/purchase/630957

Market segment by Regions/Countries, this report covers

United States, Europe, China, Japan, Southeast Asia, India, Central and South America

The study objectives of this report are:

To analyze global Orally Disintegrating Tablets status, future forecast, growth opportunity, key market and key players.

To present the Orally Disintegrating Tablets development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Orally Disintegrating Tablets are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered

About Us:

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Contact Us

Mr. Jeet Jain

Sales Manager

[email protected]

+1-240-284-8070

+44-20-3290-4151

Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Tags

Related Articles

Close